EDGAR Filing Documents for 0001354457-09-000038

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:

SEC Accession No. 0001354457-09-000038

Filing Date

2009-02-17

Accepted

2009-02-17 10:39:37

Documents

Confirming Copy

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	25-NSE
1		primary_doc.xml	25-NSE	1098
2		ingndelistreason.txt	EX-99.25	1684
	Complete submission text file	0001354457-09-000038.txt		4714

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701

Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310

INTROGEN THERAPEUTICS INC (Subject) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 000-21291
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9600 BLACKWELL RD ROCKVILLE MD 20850

Business Address 9600 BLACKWELL RD ROCKVILLE MD 20850 301-978-4144

NASDAQ Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE